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Effect of Chinese herbal compound Tengmei
decotion on IL-17/NF-B signal pathway in
synovium tissue of rat arthritis models
induced by type II collage
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Purpose: To investigate the biological effect of IL-17/NF-
B immune inﬂammatory pathway on pathological damage
in synovium tissue of Rheumatoid arthritis (RA) and study in
regulation mechanism of Chinese herbal compound Tengmei
decotion for IL-17/NF-B signal pathway.
Methods: To establish collagen II-induced rats arthri-
tis(CIA)models. The successful models of SD rats were
randomly divided intomodel group, positive group, and high-,
medium-groupsofChinesemedicine, 6 rats in eachgroup. The
normal control and model groups were given distilled water
(10mlkg-1d) by gavage. The positive drug group was given
leﬂunomide (1.87gkg-1d) by gavage. The high and medium
dose Chinese medicine groups were given crude medicine of
31.8 gkg-1d and 15.9 gkg-1d by gavage. After twelve weeks
of treatment intervention, all SD rats were executed, the
blood and synovium tissue samples were kept for detecting
IL-17, NF-KB P65 mRNA transcription and protein expression
by RT-PCR, WESTEN BLOT and ELISA Analysis, and detecting
inﬂammatory inﬁltration in synovium tissue by Histopatho-
logical analysis.
Results: (1)Compared to the normal control group, lev-
els of mRNA transcription and protein expression of IL-17
and NF-B P65 were signiﬁcantly up-regulated (P < 0.01) in the
model group. Compared to the model group, levels of mRNA
transcription and protein expression of IL-17 and NF-B P65
were signiﬁcantly down-regulated in the positive and Chinese
medicine groups (P < 0.01).(2) Histopathological analysis dis-
played that mild hyperplasia of epithelial cells covering the
articular cartilage synovium, joint cavity narrowing, and mild
inﬂammatory lymphocytes inﬁltration in model group, with
joint lesions improved in treatment groups.
Conclusion: The molecular mechanisms of Chinese herbal
Tengmei decotion in inhibiting immune inﬂammatory patho-
logical damage in synovium of CIA rats models related to its
effects on IL-17/NF-B pathway.
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Chemoprotective activity of KIOM-CRC#50, an
ethanol extract of a medicinal plant, in
cisplatin-induced cachectic mouse model
Jinhee Kim, Jong-Shik Park, Jun Lee,
You Jin Lee, Eun-Sang Cho, Ok-Sun Bang
Korea Institute of Oriental Medicine
Purpose: Cachexia is one of the dose-limiting side effects
of chemotherapy that seriously threatens the survival and
quality of life of cancer patients. More than 80% of can-
cer patients of later stages suffers from cachexia, commonly
deﬁned as an involuntary weight loss over 5% of normal
body weight. In this study, we investigated KIOM-CRC#50,
the ethanol extract of a medicinal plant traditionally used in
many countries, as a potential chemoprotective agent against
chemotherapy-induced cachexia as well as other side effects
including nephrotoxicity and hematotoxicity.
Methods: Dried plant materials were ﬁnely pulverized and
immersed in 70% (v/v) ethanol (100 g/L). Anti-cancer potential
and anti-cancer cachectic activity of KIOM-CRC#50were deter-
mined in an orthotopic lung xenograft model using Balb/c
nudemice.Male C57BL6mice at the age of 6∼8weekswere uti-
lized to evaluate the chemoprotective activity of KIOM-CRC#50
in cisplatin-induced cachexia model. Body weight change,
blood cell count, and biochemical analysis of sera were mea-
sured and analyzed for determining its effectiveness.
Results: Mice with orthotopic lung tumors experienced
progressiveweight loss as tumorprogress. Oral administration
of KIOM-CRC#50 effectively ameliorated cancer progression-
related weight loss in these mice. Daily administration of
KIOM-CRC#50 also alleviated bothnadir andmaximumweight
loss induced by high dose cisplatin treatment in C57BL6 mice.
Cisplatin treatment resulted in elevated blood levels of BUN
(blood urea nitrogen) and AST (aspartate aminotransferase)
levels, however, oral administration of KIOM-CRC#50 in these
mice reduced the levels of BUN and AST elevated by cis-
platin treatment. Additionally, KIOM-CRC#50 treatment also
markedly increase the number of WBC in cisplatin-treated
mice.
Conclusion: In summary, our data demonstrated the
effectiveness of KIOM-CRC#50 in alleviating chemotherapy-
induced cachexia and other side effects, as well as cancer-
progression induced weight loss, suggesting that it could be
an important source for the development of novel chemopro-
tective agent.
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